| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |